Novo Nordisk A/S (NVO)

Novo Nordisk Revenue

In the year 2025, Novo Nordisk had annual revenue of 309.06B DKK with 6.43% growth. Novo Nordisk had revenue of 79.14B in the quarter ending December 31, 2025, a decrease of -7.63%.

• Revenue (ttm): 309.06B DKK
• Revenue Growth: +6.43%
• P/S Ratio: 3.65
• Revenue / Employee: 4,446,644 DKK
• Employees: 69,505
• Market Cap: 177.28B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	309.06B	18.66B	6.43%
Dec 31, 2024	290.40B	58.14B	25.03%
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%
Dec 31, 2019	122.02B	10.19B	9.11%
Dec 31, 2018	111.83B	135.00M	0.12%
Dec 31, 2017	111.70B	-84.00M	-0.08%
Dec 31, 2016	111.78B	3.85B	3.57%
Dec 31, 2015	107.93B	19.12B	21.53%
Dec 31, 2014	88.81B	5.23B	6.26%
Dec 31, 2013	83.57B	5.55B	7.11%
Dec 31, 2012	78.03B	11.68B	17.60%
Dec 31, 2011	66.35B	5.57B	9.16%
Dec 31, 2010	60.78B	9.70B	18.99%
Dec 31, 2009	51.08B	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 25, 2026

Data Sources Report a data error